Phibro Animal Health (PAHC) Long-Term Deferred Tax (2019 - 2026)

Phibro Animal Health's Long-Term Deferred Tax history runs 8 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• In Q1 2026, Long-Term Deferred Tax fell 57.8% year-over-year to $15.3 million; the TTM figure through Mar 2026 stood at $15.3 million (down 57.8% YoY), while the FY2025 annual figure was $25.5 million, up 31.89% from the prior year.
• Long-Term Deferred Tax was $15.3 million for Q1 2026 at Phibro Animal Health, down from $19.5 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $36.2 million in Q1 2025 to a low of $4.1 million in Q1 2022.
• Historically, Long-Term Deferred Tax has averaged $16.1 million across 5 years, with a median of $14.5 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Long-Term Deferred Tax soared 184.22% in 2024, then sank 57.8% in 2026.
• A 5-year view of Long-Term Deferred Tax shows it stood at $6.3 million in 2022, then soared by 123.91% to $14.1 million in 2023, then jumped by 139.16% to $33.8 million in 2024, then tumbled by 42.29% to $19.5 million in 2025, then retreated by 21.74% to $15.3 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $15.3 million (Q1 2026), $19.5 million (Q4 2025), and $23.5 million (Q3 2025), per Business Quant data.